Jun 24, 2021 11:45 AMIRB #2

Video Conferencing/9025 Maloney, HUP

Jun 30, 2021 12:00 PMIRB #5

Video Conferencing/Human Research Protections Program Office of the Institutional Review Board 3600 Civic Center Blvd, 9th Floor

Jul 06, 2021 4:00 PMIRB #6

Cheston Conference Room, Pennsylvania Hospital

Jul 07, 2021 11:00 AMIRB #7

Video Conferencing/Human Research Protections Program Office of the Institutional Review Board 3600 Civic Center Blvd, 9th Floor

Jul 09, 2021 10:00 AMIRB #3

Video Conferencing/9025 Maloney, HUP

Jul 12, 2021 11:45 AMIRB #1

Video Conferencing/Human Research Protections Program Office of the Institutional Review Board 3600 Civic Center Blvd, 9th Floor

Jul 13, 2021 10:45 AMIRB #4

Video Conferencing/Human Research Protections Program Office of the Institutional Review Board 3600 Civic Center Blvd, 9th Floor

Jul 19, 2021 12:00 PMIRB #8

Video Conferencing/Human Research Protections Program Office of the Institutional Review Board 3600 Civic Center Blvd, 9th Floor

See future meetings »

May 27, 2021 5:15 PMSummer 2021 Phase III Research Resumption

As of May 21, 2021, Research Resumption has moved into Phase III. More details are online here: https://research.upenn.edu/resources/resumption/phase3. As noted in the link above, "centralized approval of research or resumption plans is not required; however, a school may elect to maintain its own policies regarding research activity." Please check with your school representatives to ensure you are compliant with local policies.

May 07, 2021 4:45 PMUpdate on IRB Billing

IRB Fee information has been updated to reflect that, as of May 6, 2021, if the IRB billing office is unable to secure a budget code for the charges from the department within two months from the date of billing, they will automatically charge the department’s 01XX01 Fund. It will then be the responsibility of the department to reallocate the charges to the correct sponsor project fund. See https://irb.upenn.edu/mission-institutional-review-board-irb/irb-fees for more information and a signed memo from the Vice Provost for Research.

Apr 02, 2021 11:00 AMThe Impact of the 21st Century Cures Act & Electronic Medical Records Access on Clinical Research

As a result of the 21st Century Cures Act, Penn Medicine is required to allow patients increased access to their electronic medical record. With the Cures Act, by default, research-related information* that is placed in the participant’s EMR will now be available within 10 days via MyPennMedicine (MPM), Penn Medicine’s patient portal. This goes into effect on April 2, 2021. Please review the IRB Guidance on the impact of 21st Century Cures Act on research protocols to determine whether you may need to submit an amendment to the IRB.

Sep 30, 2020 11:15 AMUpdated Protocol Supplement for Requests to Rely on External IRBs

The IRB has released and updated version of the Protocol Supplement for Requests to rely on an External IRB. This form is available online here: https://irb.upenn.edu/forms

Aug 01, 2020 2:30 PMThe IRB Office has moved!

The IRB Office has moved! Please note that as of 8/5/2020, the IRB office is located at 3600 Civic Center Boulevard, 9th Fl. Philadelphia, PA 19104

Mar 17, 2020 10:30 AMImportant: Message from Emma Meagher, MD - Clinical Research Update#3

The requirements regarding the execution of clinical research will apply until further notice.

Mar 13, 2020 12:30 PMPenn Medicine Updated Clinical Research Guidance in relation to COVID-19 (Corona Virus)

Based on the March 13th, 2020 communication from Penn Medicine we are updating the guidance regarding the execution of clinical research.

Mar 10, 2020 10:30 AMPenn Medicine Guidance on Human Subjects Protections Considerations Related to COVID-19

PLEASE NOTE: Due to COVID-19 (Coronavirus), starting Thursday, March 12th in-person IRB Office Hours will be cancelled for the near future. IRB staff will be available during this time by telephone. Please reference the staff directory.

See past news »

IRB Educational Series Archive - Click here to download slides presented at various IRB training sessions

  • Minimal Risk Studies for First Time Submitters (Social/Behavioral/Educational Science) : Provides a full background for new submitters on what the IRB is & how they relate to your study, as well as tips to navigate your first SBS submission
  • Minimal Risk Studies for First Time Submitters (Biomedical Science) : Presents an introduction to IRB submissions for biomedical students & researchers, including a thorough outline of whether your project requires IRB review & tips for submitting
  • Comparative Effectiveness Trials : Outlines the landscape of considerations from the IRB when evaluating comparative effectiveness trials, including what study teams should outline in both their protocols & informed consent forms to facilitate review
  • The Common Rule : A comprehensive outline of what the Common Rule entails, including an outline of what’s changing (including broad consent, elements for consent, & ongoing requirements for continuing review) as well as how this will impact the submission of your studies
  • How to Conduct an IRB Reliance Agreement : Great for biomedical teams considering NIH funding. A complete overview of what reliance agreements are & how they work, as well as what you need to know as a submitter in order to request & obtain an agreement; also reviews expectations moving forward if relying on the Penn IRB
  • Got Data? What you need to Protect Your Research at Penn : Discussions of common concerns raised with data protection plans as well as best practices & considerations to better protect the data of your study; also includes a thorough refresher of the components & requirements outlined by HIPAA protections